| European Case Law Identifier: | ECLI:EP:BA:2017:T193613.20170627 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 27 June 2017 | ||||||||
| Case number: | T 1936/13 | ||||||||
| Application number: | 06841451.5 | ||||||||
| IPC class: | A61K 9/32 A61K 31/551 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | ORAL FORMULATION OF ANHYDROUS OLANZAPINE FORM I | ||||||||
| Applicant name: | Laboratorios Lesvi, S.L. | ||||||||
| Opponent name: | Dr Schüssler Andrea Agrobiogen GmbH Biotechnologie |
||||||||
| Board: | 3.3.07 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Inventive step - main and auxiliary requests (no); bonus effect. | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131936eu1.html
Date retrieved: 17 May 2021